SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: dalroi who wrote (2)8/25/2003 4:42:11 PM
From: scaram(o)uche  Read Replies (1) of 684
 
>> just entering another respected stock
Kdus.OB cash around 1.9 trading 1.07 <<

Since you made (5 April 2000) that recommendation, it's up 39%.

We were compiling ideas during the worst of times. How many other recommendations -- made early to this thread --have performed well?

1. How many of the suggestions made to this thread played well?

2. Of those that have "performed", are there others that still sell at a significant discount to cash?

KDUS specifics..... the Axiom play bombed, and got translated into a small stake in (from my perspective) the highly respected SQNM. Leverage there is gone (or waiting for Tomato, circa 2020). But it appears that a KDUS-derived adenosine receptor antagonist may have entered (Solvay) clinical testing.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext